Global Embolization Particle Market Size, Share, Trends and Forecast 2022-2030

Description

Market Analysis and Insights: Global Embolization Particle Market
Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor cells.

Due to the COVID-19 pandemic, the global Embolization Particle market size is estimated to be worth US$ 2329.4 million in 2022 and is forecast to a readjusted size of US$ 5248.9 million by 2028 with a CAGR of 14.5% during the review period. Fully considering the economic change by this health crisis, Microspheres accounting for % of the Embolization Particle global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Uterine Fibroid Embolization segment is altered to an % CAGR throughout this forecast period.

North America is the largest region of Embolization Particle, with a market share about 40%. It was followed by Europe with 30%. Sirtex Medical, Merit Medical, Cook Medical, BTG Medical and Boston Scientific Corporation are the top 5 manufacturers of industry, and they had about 80% combined market share.

Market Segments

The authors of this research report have explored the key segments: Type and Application. The report offers an in-depth breakdown of type and application segments and their sub-segments. The lucrativeness and growth potential have been looked into by the industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments based on sales, price, and revenue for the period 2017-2028. The specialists, to broaden the understanding of the users, have done value chain and raw material analysis in this section.

Segment by Type

Microspheres

Particles (e.g. PVA Particles, Gelfoam Particles)

Drug-eluting Beads (DEBs)

Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)

Segment by Application

Uterine Fibroid Embolization

Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)

Liver Tumor Embolization

Trauma Embolization

Others

Consequence of Covid-19 Pandemic

The authors of this study have enlightened the readers on the rise and effect of the Covid-19 outbreak on the development. They have investigated the changes brought about in the demand/supply side, consumption, supply chain, and sales/manufacturing. The readers will get familiar with the measures that have helped the key players to bring the Embolization Particle market back to the pre-covid levels.

Trends & Prospects

In this segment of the report, the specialists have delved into the key growth opportunities that are likely to emerge. This will aid the key players to simplify complex issues related to business and frame future strategies to compete in this competitive environment. This section will certainly assist the players to boldly position their business.

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

Competitive Outlook

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and share analysis of the prominent players are also provided in this section. They have also provided reliable sales and revenue data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

Sirtex Medical

Merit Medical

Cook Medical

BTG Medical

Boston Scientific Corporation

Terumo Corporation

HENGRUI Medical

INterface BIOmaterials B.V.

Alicon

TABLE OF CONTENT

1 Study Coverage
1.1 Embolization Particle Product Introduction

1.2 Market by Type

1.2.1 Global Embolization Particle Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Microspheres

1.2.3 Particles (e.g. PVA Particles, Gelfoam Particles)

1.2.4 Drug-eluting Beads (DEBs)

1.2.5 Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)

1.3 Market by Application

1.3.1 Global Embolization Particle Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Uterine Fibroid Embolization

1.3.3 Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)

1.3.4 Liver Tumor Embolization

1.3.5 Trauma Embolization

1.3.6 Others

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Embolization Particle Sales Estimates and Forecasts 2017-2028

2.2 Global Embolization Particle Revenue Estimates and Forecasts 2017-2028

2.3 Global Embolization Particle Revenue by Region: 2017 VS 2021 VS 2028

2.4 Global Embolization Particle Sales by Region

2.4.1 Global Embolization Particle Sales by Region (2017-2022)

2.4.2 Global Sales Embolization Particle by Region (2023-2028)

2.5 Global Embolization Particle Revenue by Region

2.5.1 Global Embolization Particle Revenue by Region (2017-2022)

2.5.2 Global Embolization Particle Revenue by Region (2023-2028)

2.6 North America

2.7 Europe

2.8 Asia-Pacific

2.9 Latin America

2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Embolization Particle Sales by Manufacturers

3.1.1 Global Top Embolization Particle Manufacturers by Sales (2017-2022)

3.1.2 Global Embolization Particle Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Embolization Particle in 2021

3.2 Global Embolization Particle Revenue by Manufacturers

3.2.1 Global Embolization Particle Revenue by Manufacturers (2017-2022)

3.2.2 Global Embolization Particle Revenue Market Share by Manufacturers (2017-2022)

3.2.3 Global Top 10 and Top 5 Companies by Embolization Particle Revenue in 2021

3.3 Global Embolization Particle Sales Price by Manufacturers (2017-2022)

3.4 Analysis of Competitive Landscape

3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Embolization Particle Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4.3 Global Embolization Particle Manufacturers Geographical Distribution

3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Embolization Particle Sales by Type

4.1.1 Global Embolization Particle Historical Sales by Type (2017-2022)

4.1.2 Global Embolization Particle Forecasted Sales by Type (2023-2028)

4.1.3 Global Embolization Particle Sales Market Share by Type (2017-2028)

4.2 Global Embolization Particle Revenue by Type

4.2.1 Global Embolization Particle Historical Revenue by Type (2017-2022)

4.2.2 Global Embolization Particle Forecasted Revenue by Type (2023-2028)

4.2.3 Global Embolization Particle Revenue Market Share by Type (2017-2028)

4.3 Global Embolization Particle Price by Type

4.3.1 Global Embolization Particle Price by Type (2017-2022)

4.3.2 Global Embolization Particle Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global Embolization Particle Sales by Application

5.1.1 Global Embolization Particle Historical Sales by Application (2017-2022)

5.1.2 Global Embolization Particle Forecasted Sales by Application (2023-2028)

5.1.3 Global Embolization Particle Sales Market Share by Application (2017-2028)

5.2 Global Embolization Particle Revenue by Application

5.2.1 Global Embolization Particle Historical Revenue by Application (2017-2022)

5.2.2 Global Embolization Particle Forecasted Revenue by Application (2023-2028)

5.2.3 Global Embolization Particle Revenue Market Share by Application (2017-2028)

5.3 Global Embolization Particle Price by Application

5.3.1 Global Embolization Particle Price by Application (2017-2022)

5.3.2 Global Embolization Particle Price Forecast by Application (2023-2028)

6 North America

6.1 North America Embolization Particle Market Size by Type

6.1.1 North America Embolization Particle Sales by Type (2017-2028)

6.1.2 North America Embolization Particle Revenue by Type (2017-2028)

6.2 North America Embolization Particle Market Size by Application

6.2.1 North America Embolization Particle Sales by Application (2017-2028)

6.2.2 North America Embolization Particle Revenue by Application (2017-2028)

6.3 North America Embolization Particle Market Size by Country

6.3.1 North America Embolization Particle Sales by Country (2017-2028)

6.3.2 North America Embolization Particle Revenue by Country (2017-2028)

6.3.3 U.S.

6.3.4 Canada

7 Europe

7.1 Europe Embolization Particle Market Size by Type

7.1.1 Europe Embolization Particle Sales by Type (2017-2028)

7.1.2 Europe Embolization Particle Revenue by Type (2017-2028)

7.2 Europe Embolization Particle Market Size by Application

7.2.1 Europe Embolization Particle Sales by Application (2017-2028)

7.2.2 Europe Embolization Particle Revenue by Application (2017-2028)

7.3 Europe Embolization Particle Market Size by Country

7.3.1 Europe Embolization Particle Sales by Country (2017-2028)

7.3.2 Europe Embolization Particle Revenue by Country (2017-2028)

7.3.3 Germany

7.3.4 France

7.3.5 U.K.

7.3.6 Italy

7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Embolization Particle Market Size by Type

8.1.1 Asia Pacific Embolization Particle Sales by Type (2017-2028)

8.1.2 Asia Pacific Embolization Particle Revenue by Type (2017-2028)

8.2 Asia Pacific Embolization Particle Market Size by Application

8.2.1 Asia Pacific Embolization Particle Sales by Application (2017-2028)

8.2.2 Asia Pacific Embolization Particle Revenue by Application (2017-2028)

8.3 Asia Pacific Embolization Particle Market Size by Region

8.3.1 Asia Pacific Embolization Particle Sales by Region (2017-2028)

8.3.2 Asia Pacific Embolization Particle Revenue by Region (2017-2028)

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 India

8.3.7 Australia

8.3.8 Taiwan

8.3.9 Indonesia

8.3.10 Thailand

8.3.11 Malaysia

8.3.12 Philippines

9 Latin America

9.1 Latin America Embolization Particle Market Size by Type

9.1.1 Latin America Embolization Particle Sales by Type (2017-2028)

9.1.2 Latin America Embolization Particle Revenue by Type (2017-2028)

9.2 Latin America Embolization Particle Market Size by Application

9.2.1 Latin America Embolization Particle Sales by Application (2017-2028)

9.2.2 Latin America Embolization Particle Revenue by Application (2017-2028)

9.3 Latin America Embolization Particle Market Size by Country

9.3.1 Latin America Embolization Particle Sales by Country (2017-2028)

9.3.2 Latin America Embolization Particle Revenue by Country (2017-2028)

9.3.3 Mexico

9.3.4 Brazil

9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Embolization Particle Market Size by Type

10.1.1 Middle East and Africa Embolization Particle Sales by Type (2017-2028)

10.1.2 Middle East and Africa Embolization Particle Revenue by Type (2017-2028)

10.2 Middle East and Africa Embolization Particle Market Size by Application

10.2.1 Middle East and Africa Embolization Particle Sales by Application (2017-2028)

10.2.2 Middle East and Africa Embolization Particle Revenue by Application (2017-2028)

10.3 Middle East and Africa Embolization Particle Market Size by Country

10.3.1 Middle East and Africa Embolization Particle Sales by Country (2017-2028)

10.3.2 Middle East and Africa Embolization Particle Revenue by Country (2017-2028)

10.3.3 Turkey

10.3.4 Saudi Arabia

11 Company Profiles

11.1 Sirtex Medical

11.1.1 Sirtex Medical Corporation Information

11.1.2 Sirtex Medical Overview

11.1.3 Sirtex Medical Embolization Particle Sales, Price, Revenue and Gross Margin (2017-2022)

11.1.4 Sirtex Medical Embolization Particle Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Sirtex Medical Recent Developments

11.2 Merit Medical

11.2.1 Merit Medical Corporation Information

11.2.2 Merit Medical Overview

11.2.3 Merit Medical Embolization Particle Sales, Price, Revenue and Gross Margin (2017-2022)

11.2.4 Merit Medical Embolization Particle Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Merit Medical Recent Developments

11.3 Cook Medical

11.3.1 Cook Medical Corporation Information

11.3.2 Cook Medical Overview

11.3.3 Cook Medical Embolization Particle Sales, Price, Revenue and Gross Margin (2017-2022)

11.3.4 Cook Medical Embolization Particle Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Cook Medical Recent Developments

11.4 BTG Medical

11.4.1 BTG Medical Corporation Information

11.4.2 BTG Medical Overview

11.4.3 BTG Medical Embolization Particle Sales, Price, Revenue and Gross Margin (2017-2022)

11.4.4 BTG Medical Embolization Particle Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 BTG Medical Recent Developments

11.5 Boston Scientific Corporation

11.5.1 Boston Scientific Corporation Corporation Information

11.5.2 Boston Scientific Corporation Overview

11.5.3 Boston Scientific Corporation Embolization Particle Sales, Price, Revenue and Gross Margin (2017-2022)

11.5.4 Boston Scientific Corporation Embolization Particle Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Boston Scientific Corporation Recent Developments

11.6 Terumo Corporation

11.6.1 Terumo Corporation Corporation Information

11.6.2 Terumo Corporation Overview

11.6.3 Terumo Corporation Embolization Particle Sales, Price, Revenue and Gross Margin (2017-2022)

11.6.4 Terumo Corporation Embolization Particle Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Terumo Corporation Recent Developments

11.7 HENGRUI Medical

11.7.1 HENGRUI Medical Corporation Information

11.7.2 HENGRUI Medical Overview

11.7.3 HENGRUI Medical Embolization Particle Sales, Price, Revenue and Gross Margin (2017-2022)

11.7.4 HENGRUI Medical Embolization Particle Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 HENGRUI Medical Recent Developments

11.8 INterface BIOmaterials B.V.

11.8.1 INterface BIOmaterials B.V. Corporation Information

11.8.2 INterface BIOmaterials B.V. Overview

11.8.3 INterface BIOmaterials B.V. Embolization Particle Sales, Price, Revenue and Gross Margin (2017-2022)

11.8.4 INterface BIOmaterials B.V. Embolization Particle Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 INterface BIOmaterials B.V. Recent Developments

11.9 Alicon

11.9.1 Alicon Corporation Information

11.9.2 Alicon Overview

11.9.3 Alicon Embolization Particle Sales, Price, Revenue and Gross Margin (2017-2022)

11.9.4 Alicon Embolization Particle Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 Alicon Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Embolization Particle Industry Chain Analysis

12.2 Embolization Particle Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Embolization Particle Production Mode & Process

12.4 Embolization Particle Sales and Marketing

12.4.1 Embolization Particle Sales Channels

12.4.2 Embolization Particle Distributors

12.5 Embolization Particle Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Embolization Particle Industry Trends

13.2 Embolization Particle Market Drivers

13.3 Embolization Particle Market Challenges

13.4 Embolization Particle Market Restraints

14 Key Findings in The Global Embolization Particle Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

Choose License Type

Checkout Inquiry Sample